Robert G. Micheletti, MD
Dermatology
Accepting new patients
Sees patients age 18 and up
Penn Dermatology Perelman
View 1 additional location
Headshot of Robert G. Micheletti, MD
Penn Medicine Provider

About me

  • Chief of Hospital Dermatology
  • Chief of Dermatology, Pennsylvania Hospital
  • Director, Cutaneous Vasculitis Clinic, Penn Vasculitis Center
  • Director, Dermatology Medical Student Elective
  • Associate Professor of Dermatology at the Hospital of the University of Pennsylvania
  • Associate Professor of Dermatology in Medicine (General Internal Medicine)

Education and training

  • Medical School: Duke University Medical Center
  • Residency: University of Pennsylvania Health System

What my patients think about me

Average Rating

518 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
March 2026
dr. micheletti is an experienced dermatologist, i feel i am in excellent hands under his care. he is kind as well, i do not feel rushed. that's important.
Anonymous
March 2026
good doctor
Anonymous
March 2026
always professional and genuinely concerned
Anonymous
March 2026
efficiency

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital
Dr. Micheletti is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Lewis W, Micheletti RG Dermal Atrophy and Lipoatrophy , Decision-Making in Dermatology: 2026


Lewis W, Micheletti RG Epidermal Atrophy , Decision-Making in Dermatology: 2026


Micheletti RG Featured in: "Vasculitis Evaluation and Management" , Dialogues in Dermatology Podcast: 2026


Micheletti RG Featured in: "Bridging Science and Support: Initiating biologics in patients with hidradenitis suppurativa" , SkinSync Podcast: 2026


Mahajan A, Song W, Walls AC, Mostaghimi A, Micheletti R, Piette EW Point-of-Care Risk Factors for Systemic Disease in Patients with Small Vessel Vasculitis of the Skin , JAMA Dermatol, 162(1): 2026,94-7


Garg A, Strunk A, Midgette B, Frasier K, Cohn E, Aarts P, Alavi A, Alhusayen R, Bechara BFG, Bettoli V, Brassard A, Brown DP, Chandran NS, Choon SE, Cohen SR, Daveluy S, Del Marmol V, Dellavalle RP, Emtestam L, Farida B, Fernandez-Penas P, Flowers RH, Frew JW, Gebauer KA, Giamarellos-Bourboulis EJ, Goldfarb N, Horváth B, Hsiao JL, Jemec G, Lowes MA, Marzano AV, Matusiak L, Micheletti RG, Oon HH, Orenstein LAV, Ortega-Loayza AG, Paek SY, Pascual JC, Piguet V, Resnik BI, Rosmarin D, Roth GM, Sayed CJ, Silva DLF, Thorlacius L, Tzellos T, van der Zee H, van Straalen K, Ingram JR Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi Approach , JAMA Dermatol, 162(1): 2026,72-9


Martin-Pozo MD, Williams EA, Bonnet KR, Kaffenberger BH, Schlundt DG, Phillips EJ; SJS Survivor Study Recovering from Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis , JAMA Dermatol, 162(1): 2026,24-30


Drucker AM, Williams E, Kaffenberger B, Dodiuk-Gad RP, Chren MM, Phillips S, Martin-Pozo M, Goh MS, Ergen E, Micheletti R, Rosenbach M, Yu A, O'Connor A, Mahan K, Phillips EJ Long-term morbidity and quality of life among survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum , Br J Dermatol, 194(1): 2026,161-63


Micheletti RG, Requena L, Callen JP Cutaneous Vasculitis and Panniculitis , Rheumatology, 9th Edition: 2026


Thomas Vazquez, Avrom Caplan, Robert Micheletti Systemic Corticosteroids , Wolverton's Comprehensive Dermatologic Drug Therapy, 5th Edition: 2026